13Apr 2023
Precision medicine in systemic lupus erythematosus

Precision medicine in systemic lupus erythematosus

The article discusses the heterogeneity of Systemic Lupus Erythematosus (SLE), an autoimmune disease, and its impact on clinical phenotype and treatment response. The identification of novel serum and urinary biomarkers can potentially predict long-term outcomes and responses to therapy. The article highlights the importance of precision medicine for the treatment of SLE, which uses individual variability to identify patient subgroups that can benefit from specific treatments. Technological advances have facilitated immune profiling, which sheds light on the cellular and molecular basis of clinical symptoms in individual patients with SLE. Peripheral blood immunophenotyping is identifying molecular networks associated with disease activity, subtype, and future relapse, which might provide biomarkers to develop stratified treatment recommendations and SLE precision medicine.

  • #rheumatology

Like

Save

Share